The rationale of magnesium as alternative therapy for patients with acute myocardial infarction without thrombolytic therapy

American Heart Journal

Volumn 132, Issue 2 II, 1996, Pages 483-486

  Shechter, M ^a   Hod, H ^a   Kaplinsky, E ^a   Rabinowitz, B ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOLYTIC AGENT; HEPARIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; NITRATE; PLACEBO;

ACUTE HEART INFARCTION; CLINICAL TRIAL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DRUG MECHANISM; FIBRINOLYTIC THERAPY; HEART ARRHYTHMIA; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE INJURY; HEART PROTECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PATIENT SELECTION; PRIORITY JOURNAL; REPERFUSION INJURY; TREATMENT OUTCOME;

EID: 0029783165     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90340-3     Document Type: Conference Paper

References (0)